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ABSTRACT The calcium release channels/ryanodine receptors (RyRs) usually form two-dimensional regular lattices in the
endoplasmic/sarcoplasmic reticulum membranes. However, the function and modulation of the interaction between neighboring
RyRs are still unknown. Here, with an in vitro aqueous system, we demonstrate that the interaction between RyRs isolated from
skeletal muscle (RyR1s) is modulated by their functional states by using photon correlation spectroscopy and [3H]ryanodine
binding assay. High level of oligomerization is observed for resting closed RyR1s with nanomolar Ca21 in solution. Activation of
RyR1s by micromolar Ca21 or/and millimolar AMP leads to the de-oligomerization of RyR1s. The oligomerization of RyR1s
remains at high level when RyR1s are stabilized at closed state by Mg21. The modulation of RyR1-RyR1 interaction by the
functional state is also observed under near-physiological conditions, suggesting that the interaction between arrayed RyR1s
would be dynamically modulated during excitation-contraction coupling. These ﬁndings provide exciting new information to
understand the function and operating mechanism of RyR arrays.
INTRODUCTION
Ryanodine receptors (RyRs) belong to the class of ion chan-
nels mediating Ca21 release from endoplasmic/sarcoplasmic
reticulum (SR), and play a pivotal role in intracellular Ca21
signaling processes, such as excitation-contraction coupling
(E-C coupling), in muscle cells (1–5). Three different iso-
forms of RyRs have been identiﬁed in mammals, designated
as skeletal (RyR1), cardiac (RyR2), and brain (RyR3) (1,2).
Intriguingly, RyRs in intact muscle cells are almost exclu-
sively found to be assembled into two-dimensional para-
crystalline arrays in SR membrane (6–9). The interaction
between neighboring RyRs may play an essential role in the
activation and termination of Ca21 release during E-C cou-
pling. The ‘‘coupled gating’’ of RyRs has been observed in
vitro for reconstituted RyRs isolated from both skeletal and
cardiac muscle cells (10,11). Recently, by analysis of the
quantal nature of Ca21 sparks, the elementary Ca21 release
events, Cheng et al. have demonstrated that the gating ki-
netics of multiple RyRs is reshaped by the array-based inter-
action between these channels (12–14). However, the nature
of the underlying RyR-RyR interaction and its modulation
during E-C coupling is still unknown.
Clearly, the investigation of the modulation of RyR-RyR
interaction by functional channel state would provide ex-
citing new information, shedding light on the function and
operating mechanism of RyR arrays. The potential RyR-RyR
interacting site is found on the conserved, clamplike subdo-
mains located at the four corners of the cytoplasmic region of
the channel protein (6–9,15). The profound conformational
changes of these domains accompanying the activation of
RyR (16–18) suggest the potential of the channel’s func-
tional states to modulate the interaction between RyRs.
Examination of RyR-RyR protein interaction in vivo would
be extremely difﬁcult given present techniques. Recently, by
electron microscopy study it has been shown that isolated
RyR1s in aqueous medium could self-assemble into a two-
dimensional array, with similar dimensions to those observed
in native SR membrane (15). Thus, it is plausible to work with
such a simple system to look at the basic features of the inter-
action between RyRs, as modulated by their functional states.
In the present work, the modulation of RyR1-RyR1 inter-
action by their functional states was studied by examining
the oligomerization and de-oligomerization of isolated RyR1s
in aqueous medium accompanying their activation by endog-
enous activators, Ca21 and AMP, and inhibitor Mg21. Photon
correlation spectroscopy (PCS), also referred to dynamic light
scattering, was employed for its high sensitivity to the aggre-
gation state of proteins in solution (19–22). The functional
state of isolated RyR1s in the presence of Ca21/AMP/Mg21
was examined by [3H]ryanodine binding assay. By analysis of
the correlation between RyR1 oligomerization and RyR1
activity, we demonstrate that the interaction between RyR1s
decreases with the activation of the channels. These ﬁndings
provide new insight for understanding the modulation and
function of the interaction between arrayed RyRs during E-C
coupling.
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MATERIALS AND METHODS
Isolation and puriﬁcation of RyR1
The isolation and puriﬁcation of RyR1 from rabbit skeletal muscle were as
described previously (22–24). All the reagents were purchased from Sigma-
Aldrich (St. Louis, MO). In brief, the heavy sarcoplasmic reticulum (HSR)
vesicles were prepared by sucrose step-gradient centrifugation
(20%:35%:40%, w/w). Then, the HSR vesicles were solubilized with 3-
[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS).
The solubilized proteins were fractionated by centrifugation on a 6–20%
linear sucrose gradient. The protein composition of 1 ml fractions was
monitored by SDS-polyacrylamide gel electrophoresis and identiﬁed by
Western blot analysis. The fraction containing highly puriﬁed RyR1 was
used for this study. The buffer for storing the isolated RyR1s contained 1 M
KCl, 20 mM K-PIPES, 100 mM EGTA, 1 mM dithiothreitol, 1 mM
diisopropylfuorophosphate, pH 7.1, with 10 mM CHAPS, and 3 mg/ml
phosphatidylcholine (PC), ;17% sucrose. The protein concentration was
;100 mg/ml. The purity of RyR1 was ;90%, as estimated from silver-
stained polyacrylamide gel.
[3H]Ryanodine binding assay
These experiments were carried out according to the method of Pessah et al.
(25). HSR vesicles (0.25 mg protein/ml) or isolated RyR1s (2 mg/ml) were
incubated at 34C for 4.5 h, with various concentrations of free Ca21, Mg21,
and AMP in binding buffer containing 20 mM PIPES, 100 mM EGTA, and
130 mM KCl-20 mM NaCl, pH 7.1, and radioligand: 1 nM [3H]ryanodine
and 14 nM ryanodine (for HSR) or 2 nM [3H]ryanodine and 3 nM ryanodine
(for isolated RyR1s).The total Ca21, Mg21, and AMP necessary for obtain-
ing the desired free concentration in binding buffer was calculated by the
new version of a computer program, Winmaxc (26). The binding reaction
was quenched by rapid ﬁltration through Whatman GF/B ﬁlters (Whatman,
Florham Park, NJ) mounted on a 48-well Brandel Cell Harvester (Brandel,
Gaithersburg, MD). The ﬁlters were rinsed three times with ice-cold wash
buffer, put into scintillation vials and shaken overnight with scintillation
ﬂuid, and bound [3H]ryanodine determined by scintillation counting (Model
LS 6000IC, Beckman-Coulter, Fullerton, CA).
Photon correlation spectroscopy
Theory
In a typical light-scattering experiment, a laser beam impinges on a solution
and the scattered light is recorded by a photomultiplier. The spatial resolu-
tion of the experiment is deﬁned by the scattered vector q, whose magnitude
is given by the Bragg formula as
jqj ¼ 4pn
l
sin
u
2
 
; (1)
where l denotes the wavelength of the scattered light, n is the refractive
index of the solution, and u is the scattering angle.
In a PCS experiment, the ﬂuctuations of the scattered light due to the
Brownian motion of the particles are analyzed in terms of an autocorrelation
function, which is proportional to the distribution of relaxation time, t, and
scattering amplitudes of the examined components (20),
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where mG is the particle mass, P(q, G) is the particle scattering factor, and
G(G) is the normalized number distribution function for the decay constant
G. G ¼ q2DT. DT is the translational diffusion coefﬁcient. If the particles
are small compared with the employed wavelength, DT can be determined
through Laplace inversion of the autocorrelation function.
From DT, the apparent hydrodynamic diameter (Dh, Z-average) of the
particles are calculated according to the Stokes-Einstein equation
Dh ¼ kBT
3phD
; (3)
where kB denotes the Boltzmann constant, T the absolute temperature, and h
the viscosity of the solvent.
In the case of large, asymmetric particles, rational motions also contribute
to the autocorrelation function. The magnitude of this effect can be roughly
estimated according to Linsay et al. (27,28).
Experimental setup
PCS measurements were performed on a Zetasizer 3000HSA (Malvern
Instruments, Malvern, Worcestershire, UK) with an He-Ne laser, operating
at a 633-nm wavelength. The scattering angle for size analysis was ﬁxed at
90 degrees. All measurements were carried out at 20C. Solvent and particle
refractive indexes were set to 1.330 and 1.520, respectively. Solvent viscos-
ity was set to 1.00 for analysis at 20C. CONTIN was chosen as the analysis
method due to its suitability for describing smooth distributions.
Sample preparation for PCS
To prepare samples for PCS measurement, the original puriﬁed RyR1 in 1 M
KCl storage buffer was diluted to a ﬁnal solution containing 130 mMK1-20
mM Na1. The diluted RyR1 samples also contained 0.3 mg/ml PC, 1 mM
CHAPS, 0.1 mM dithiothreitol, 100 mM EGTA, 20 mM PIPES, 10 mg/ml
RyR1, and the desired concentration of Ca21 [Ca21]f/[Mg
21]f/AMP, pH
7.1. After dilution, all of the RyR1 samples were immediately mixed (300
rpm) on a Thermomixer (Eppendorf, Westbury, NY) at 20C for 30 min be-
fore PCS measurement. A control sample, which contained 1 mM CHAPS
and 0.3 mg/ml PC in the absence of RyR1, was also examined (22). It was
found that PC and CHAPS formed ;26-nm homogeneous particles inde-
pendent of the presence of the Ca21, Mg21, and AMP used in this work.
RESULTS
Identiﬁcation of puriﬁed RyR1
First, the purity and activity of the puriﬁed RyR1 sample
were identiﬁed. Fig. 1 A shows the SDS-PAGE analysis of a
puriﬁed RyR1 sample. Two bands, indicated by arrows, were
identiﬁed as of RyR1 origin by Western blotting with anti-
RyR antibody 34C. The ﬁrst band is consistent with the in-
tact RyR1 monomer, whereas the second band represents a
cleaved RyR1 fragment (23,29). Obviously, only a small
amount of RyR1 underwent proteolysis during puriﬁcation.
Besides these two bands, only one contaminating band be-
tween 97 KDa and 116 KDa, generated by Ca21-ATPase
(23,29), was observed. The purity of intact RyR1 was;90%.
To test if puriﬁed RyR1 retains activity, Ca21-dependence of
[3H]ryanodine binding was examined. Similar to HSR, a bell-
shaped Ca21 dependence of [3H]ryanodine binding was ob-
tained for puriﬁed RyR1, with a peak binding at ;10 mM
free Ca21 ([Ca21]f) (Fig. 1 B), and consistent with previous
results (2,4,30). In addition, [3H]ryanodine binding by puri-
ﬁed RyR1 maintained its response to activation by AMP and
inhibition by Mg21 (data not shown). Given the broader
[3H]ryanodine binding curve for puriﬁed RyR1 relative to
HSR, it is likely that other proteins in HSR contribute to the
Ca21 responsiveness of the channel.
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Modulation of RyR1 oligomerization by Ca21
Previous studies have demonstrated that puriﬁed RyR1 could
oligomerize in aqueous solution near physiological ionic
strength (15,22). To investigate the modulation of RyR1-
RyR1 interaction by Ca21, the oligomerization state of RyR1s
in the medium containing 130 mM KCl-20 mM NaCl with
different concentration of Ca21 was examined by PCS.
The representative size distributions of RyR1 samples mea-
sured in the presence of resting 0.1 mM [Ca21]f and acti-
vating 50 mM [Ca21]f are presented in Fig. 2 A. At 0.1 mM
[Ca21]f, three peaks were usually observed (Fig. 2 A, left
panel). As indicated in our previous article (22), the peak at
;30 nm represents the distribution of PC-CHAPS particles
(;26 nm) and the monodisperse RyR1s. Besides this peak,
two peaks at;200 nm and;700 nm were usually observed,
reﬂecting the high oligomerization state of RyR1s. Some-
times, we only observed two peaks. Besides the peak at;30
nm, the second peak is broad to cover 100–1000 nm. In the
presence of 50 mM [Ca21]f, the oligomerization degree was
decreased. Aside from the 30-nm peak, only one additional
peak at 200–300 nm was usually observed (Fig. 2 A, right
panel).
The average hydrodynamic diameter (Z-average) obtained
from PCS measurement provides a way to semi-quantify the
oligomerization state of RyR1 samples, although this param-
eter does not represent the actual dimensions of RyR1 olig-
omers (19). With this parameter, we quantitatively analyzed
the oligomerization level of RyR1 samples accompanying
the increase/decrease of [Ca21]f (Fig. 2 B). When [Ca
21]f
was increased from 0.1 mM to 50 mM, the Z-average de-
creased from 65.46 3.0 nm (n¼ 12) to 49.66 1.2 nm (n¼ 8).
To test if such Ca21-modulation of RyR1 oligomerization is
reversible, EGTA was added to the sample to reduce [Ca21]f
from 50 mM to ;0.1 mM. After the addition of EGTA, the
Z-average gradually increased and reached plateau equiva-
lent to control levels after ;45 min (Fig. 2 B). These results
demonstrate that the decreased oligomerization of RyR1s in
the presence of activating mM [Ca21]f could be completely
reversed after a decrease in [Ca21]f.
Then the [Ca21]f dependence of oligomerization of RyR1s
was examined in detail (Fig. 3). To investigate the cor-
relation between Ca21-dependent RyR1 oligomerization
and Ca21-dependent RyR1 activity, the Ca21 dependence
of [3H]ryanodine binding of isolated RyR1s was also de-
termined. As shown in Fig. 3, a close correlation between
RyR1 de-oligomerization and RyR1 activation was ob-
served. At 0.1 mM [Ca21]f, the Z-average began to decrease
with the slight activation of RyR1s, as reﬂected by the small
increase in [3H]ryanodine binding. When [Ca21]f was
increased from 0.1 mM to 1 mM, the Z-average decreased
sharply from 65.46 3.0 nm (n ¼ 10) to 52.96 1.8 nm (n ¼
10), in close correspondence with the acute increase of RyR1
[3H]ryanodine binding activity. In the range of 1–100 mM
[Ca21]f, the Z-average decreased very slowly. The Hill
constants and coefﬁcients were derived from our Ca21
dependence of [3H]ryanodine binding curves, as described
by Meissner et al. (31). As calculated with these parameters,
the percentage of RyR1 bound with Ca21 at their activation
sites slowly increased from 85.9% at 1 mM [Ca21]f to 99.7%
at 100 mM [Ca21]f. Accordingly, the Z-average decreased
slowly from 52.9 6 1.8 nm (n ¼ 10) at 1 mM [Ca21]f to
48.6 6 1.6 nm (n ¼ 10) at 100 mM [Ca21]f. Such close
correlation between RyR1 de-oligomerization and RyR1
activation by Ca21 suggests that RyR1 oligomerization is
related to RyR1 functional states.
FIGURE 1 Identiﬁcation of puriﬁed RyR1. (A)
Silver-stained polyacrylamide gel (3–20%) of puriﬁed
RyR1 preparations (1 mg). (B) Ca21 dependence of
[3H]ryanodine binding to HSR vesicles and puriﬁed
RyR1 in binding buffer with 130 mM KCl-20 mM
NaCl. Each assay was performed on duplicate samples
and repeated twice.
1694 Hu et al.
Biophysical Journal 89(3) 1692–1699
Modulation of RyR1 oligomerization by AMP
ATP, another potent activator of RyR1, exists in resting
skeletal muscle ﬁbers at a concentration of 6–8 mM. In this
study, we investigated the effect of AMP, an ATP analog, on
RyR1 oligomerization. Fig. 4 A shows the results when
RyR1s were activated by 5 mM AMP or/and 50 mM Ca21.
In the absence of Ca21/AMP, the Z-average of 10 mg/ml
RyR1 sample was 67.86 3.0 nm (n¼ 12) when RyR1s were
at their closed state as reﬂected by the low ryanodine bound.
In the presence of 5 mMAMP, the [3H]ryanodine bound was
increased to 53.9 6 1.8 pmol/mg protein (n ¼ 3), and the
Z-average was decreased to 51.16 1.6 nm (n¼ 8), similar to
that obtained with 50 mM [Ca21]f (49.6 6 1.2 nm (n ¼ 8)).
Thus, the activation of RyR1s by AMP was also accompa-
nied by the de-oligomerization of RyR1s.
When RyR1 was fully activated by the co-presence of
50 mM [Ca21]f and 5 mM AMP, the [
3H]ryanodine bound
further increased to 124.8 6 9.7 pmol/mg protein (n ¼ 3),
and the Z-average was further decreased to 38.1 6 0.8 nm
(n ¼ 12) (Fig. 4 A). This indicates the additive effect of acti-
vating Ca21 and AMP on the de-oligomerization of RyR1s.
Such effect was further investigated by measuring the Ca21-
dependent oligomerization of RyR1s in the presence of 5 mM
AMP. As shown in Fig. 4 B, compared to the curve obtained
without AMP, the AMP did not change the overall tendency,
but did lower the Z-average levels at all measured Ca21
concentrations.
Modulation of RyR1 oligomerization by Mg21
Mg21 is an inhibitor of RyR. It also binds to Ca21 activation
sites, but inhibiting RyR1 activity in doing so (4,30). Mg21
modulation of RyR1 oligomerization was also investigated
and the result was shown in Fig. 5. For comparison, the Ca21
dependence of Z-average was also presented in this ﬁgure.
Evidently, there was signiﬁcant difference between the ef-
fects of Ca21 and Mg21 on RyR1 oligomerization. In con-
trast to the continuous decrease of Z-average when [Ca21]f
was increased from 3 nM to 100 mM, the Z-average value
remained at a high level (;68 nm) with [Mg21]f up to 500
mM. These observations indicate that RyR1s retain the high
oligomerization state when RyR1s are ensured at their closed
state by Mg21.
Modulation of RyR1 oligomerization by Ca21
under near-physiological conditions
Under physiological conditions in resting skeletal muscle
ﬁbers, Mg21 and ATP are present at 1 mM and 6–8 mM con-
centrations, respectively (32). During E-C coupling, the con-
centration of Ca21 near RyR1 arrays would increase rapidly.
To investigate the modulation of RyR1-RyR1 interaction
during this process, the Ca21-dependence of Z-average and
FIGURE 3 Correlation of Ca21 dependence of the Z-average and Ca21
dependence of [3H]ryanodine binding for puriﬁed RyR1. All experiments were
performed in solution containing 130 mM K1-20 mM Na1. [3H]ryanodine
binding assay was performed on duplicate samples and repeated three times.
The samples for PCS measurements contained 10 mg/ml RyR1. Data are
presented as mean 6 SD for 3–5 independent experiments.
FIGURE 2 Modulation of RyR1 oligomerization by Ca21. (A) Represen-
tative size distributions of RyR1 samples measured by PCS in the presence
of 0.1 mM [Ca21]f (left panel) and 50 mM [Ca
21]f (right panel). All the
samples contained 10 mg/ml RyR1. Similar results were obtained in other 10
experiments. (B) The reversibility of Ca21-modulated RyR1 oligomeriza-
tion. Statistical representation of the Z-average of RyR1 sample before and
after the decrease of [Ca21]f. The Z-average obtained in the presence of
0.1 mM [Ca21]f was used as control. All the samples contained 10 mg/ml
RyR1. Data are presented as mean 6 SD for 3–5 independent experiments.
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Ca21-dependence of [3H]ryanodine binding were both ex-
amined (Fig. 6). In the presence of up to 0.1 mM [Ca21]f,
RyR1s retained a high level of oligomerization when RyR1s
were in their closed state, as determined by [3H]ryanodine
binding. When RyR1 was activated by further increasing
[Ca21]f, the Z-average quickly decreased to lower levels, in-
dicating that de-oligomerization of RyR1s also accompanied
the activation of RyR1s under near-physiological aqueous
conditions.
DISCUSSION
Modulation of RyR1-RyR1 interaction by the
functional states of RyR1s
In the present work, Ca21, AMP, and Mg21 modulation of
RyR1 oligomerization was systematically investigated and
the basic rules were obtained. Obviously, several lines of ev-
idence support that the interaction between RyR1s is closely
correlated with their functional states.
First, RyR1-RyR1 interaction decreases accompanying
the activation of the channels. Strong oligomerization is
observed for closed RyR1s with nanomolar Ca21 in solution.
Activation of RyR1s by 50 mM [Ca21]f or 5 mM AMP leads
to the de-oligomerization of RyR1s (Fig. 2 and Fig. 4 A).
Second, the decreased degree of RyR1-RyR1 interaction
is closely correlated with the increased level of RyR1 ac-
tivity. In the presence of Ca21, the decrease in Z-average is
always closely correlated with the Ca21-activation level
of RyR1s (Fig. 3). In the co-presence of Ca21 and AMP,
Z-average decreases to lower level with the additive activa-
tion of RyR1s by Ca21 and AMP (Fig. 4, A and B).
FIGURE 4 Modulation of RyR1 oligomerization by AMP. (A) Correla-
tion of Z-average and ryanodine binding with the activation of RyR1s by
5 mM AMP or/and 50 mM [Ca21]f. (B) Effect of 5 mM AMP on the Ca
21
dependence of the Z-average. All experiments were performed in solution
containing 130 mM K1-20 mM Na1. [3H]ryanodine binding assay was
performed on duplicate samples and repeated three times. The samples
for PCS measurements contained 10 mg/ml RyR1. Data are presented as
mean 6 SD for 3–5 independent experiments.
FIGURE 5 Comparison of Mg21 and Ca21 dependence of the Z-average.
All experiments were performed in solution containing 130 mM K1-20 mM
Na1. All samples contained 10 mg/ml RyR1. Data are presented as mean6
SD for 3–5 independent experiments.
FIGURE 6 Correlation of Ca21 dependence of the Z-average and Ca21
dependence of [3H]ryanodine binding obtained in 130 mM K1-20 mM Na1
solutions with 1 mM Mg21 and 5 mM AMP. [3H]ryanodine binding assay
was performed on duplicate samples and repeated three times. All samples
for PCS measurements contained 10 mg/ml RyR1. Data are presented as
mean 6 SD for 3–5 independent experiments.
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Third, RyR1-RyR1 interaction remains at a high level when
RyR1s are stabilized at a closed state by Mg21. Functional
studies have indicated that Ca21 binds to its activation sites
with a Kd of;1 mM, whereas Mg21 binds to these sites with
a Kd of 20;50 mM by inhibiting RyR1 activity (4,30). As
shown in Fig. 5, the increase of Mg21 from low nM to 500
mM, which stabilizes RyR1 in its closed state, does not induce
the de-oligomerization of RyR1. The signiﬁcant difference
between the effects of Ca21 and Mg21 on RyR1 oligomer-
ization further indicates that the de-oligomerization of RyR1 is
correlated with the activation of RyR1.
Thus, from the analysis of the correlation between RyR1
oligomerization and RyR1 activity, we demonstrate that the
RyR1-RyR1 interaction is potently modulated by their func-
tional states. Strong interaction exists between resting closed
RyR1s. The activation of RyR1s leads to the decrease in
RyR1-RyR1 interaction.
RyR1 conformational relevance
of such modulation
From the intuitive point of view, such modulation of RyR1-
RyR1 interaction is related to the conformational change(s)
of RyR1. Using techniques of electron microscopy, it has
been demonstrated that with activation of RyR1, both
transmembrane domain and cytoplasmic domain undergo
conformational changes (16,17). A profound conforma-
tional change is found on the clamp regions, located on the
four corners of the cytoplasmic domain of the channel
(16,17). It should be noted that this clamp region is the
domain at which RyR1s interact with each other to form
regular lattices in SR membrane or in solution (6–9,15).
The clamp regions undergo a stepwise conformational
change with the transient/full activation of RyR1 (17).
Correspondingly, we found in our work that RyR1-RyR1
interactions decreased step by step with the transient
activation of RyR1 by 50 mM Ca21, and full activation
of RyR1 by 50 mM Ca21 and 5 mM AMP (Fig. 4 A). Such
close correlation between RyR1-RyR1 interaction, as
measured by PCS, and conformational change in clamp
regions suggests that the clamp regions are possibly the
structural basis for the modulation of the interaction be-
tween RyR1s by their functional states. Although it would
be extremely interesting, mechanistically, to know whether
de-oligomerization occurs before or after RyR1 channel
opening, the techniques used here are not kinetically sen-
sitive enough to distinguish between these two possibilities.
Implication for function and operating
mechanism of RyR arrays
The functional state modulated RyR1-RyR1 interaction is also
observed under near-physiological conditions (Fig. 6), sug-
gesting that the interaction between arrayed RyR1s would be
dynamically modulated during E-C coupling. Such modu-
lation provides exciting new information to understand the
function and operating mechanism of RyR arrays.
First, the strong interaction between closed RyR1s pro-
vides a novel stability mechanism for arrayed RyR1s at rest-
ing conditions. By forming a close contact, every RyR1 can
be ensured at a quiescent closed state by the stabilization
from neighboring RyR1s. In skeletal muscle, some RyR1s in
two-dimensional array are respectively apposed to a dihy-
dropyridine receptor (DHPR) tetrad (7,8). Although DHPR
tetrads may exert inhibition on the apposing RyR1s (33–36),
those RyR1s without the apposed DHPR tetrads may be
stabilized by the strong RyR1-RyR1 interaction. In cardiac
muscle, DHPR may not exert inhibition on RyR2s because
DHPRs are randomly arranged, without their tetrad correla-
tion to RyR2s (7,8). In addition, RyR2 is more easily activated
by Ca21 noise due to its higher sensitivity to the activation of
Ca21 (37,38). But the stability of RyR2s still can be achieved
if a strong oligomeric interaction also exists between arrayed
RyR2s under resting conditions. Themodulation of the oligo-
merization of RyR2s by their functional states is required to
be further elucidated.
Second, the activation-induced decrease in RyR1-RyR1
interaction provides insight for understanding the operation
of activated RyR1 arrays during E-C coupling. In native
RyR1 two-dimensional arrays, activated RyR1s may not
de-oligomerize with the support of lipid bilayer. But the
interaction between neighboring RyR1s may also decrease
accompanying the conformational change(s) with the acti-
vation of RyR1s. With the loose association between RyR1s,
opened RyR1s would tend to behave more like independent
channels. Every RyR1 in the array could then be more freely
closed by multiple possible physiological mechanisms, i.e.,
stochastic closing of RyRs, Ca21-induced inactivation of
RyRs, SR Ca21 depletion, etc. (39–41).
Third, the recovered strong interaction between neighbor-
ing closed RyR1s may contribute to the rapid termination of
E-C coupling. During E-C coupling, once the neighboring
RyR1s in two-dimensional array return from activated state
to their resting closed state, the recovered RyR1-RyR1 strong
interaction may stabilize them in closed state, efﬁciently in-
hibiting the reactivation of these channels. Thus the termi-
nation of E-C coupling could be facilitated.
Many proteins are found to cluster in the membrane, but
their physiological roles are often obscure (42–44). In the
present work, by quantitatively studying RyR1 oligomeri-
zation/de-oligomerization within an aqueous system, we
have discovered a basic rule that RyR1-RyR1 oligomeric in-
teraction is inversely related to their activation level. These
ﬁndings provide a new experimental paradigm in our attempts
to understand the functional and operational signiﬁcance of
RyR arrays. Furthermore, our experimental paradigm opens
the possibility of looking at functional interactions between
RyR-interacting SR proteins on the functional and oligomeric
state of RyR channels.
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